Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
Editorials & Other Articles
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
Health
Related: About this forumFDA lets Philip Morris market Zyn nicotine pouches as less harmful than cigarettes
Politics
FDA lets Philip Morris market Zyn nicotine pouches as less harmful than cigarettes
Published Tue, Jun 30 2026 12:52 PM EDT
Updated Tue, Jun 30 2026 4:24 PM EDT
Luke Fountain
@Luke_Fountain25
KEY POINTS
The FDA will allow 20 Philip Morris-owned Zyn nicotine pouch products to carry a modified-risk claim saying switching from cigarettes lowers the risk of several smoking-related diseases.
The decision gives Philip Morris a major marketing win for one of the fastest-growing nicotine products as cigarette sales decline in the U.S.
° Public health critics warn that flavored pouches, social media promotion and workplace use could normalize nicotine for people who were not previously smokers.

In this photo illustration, Zyn nicotine cases are seen on a table on Jan. 29, 2024, in New York City.
Michael M. Santiago | Getty Images
The Food and Drug Administration on Tuesday cleared Philip Morris-owned Zyn nicotine pouches to be marketed as less harmful than cigarettes, giving the tobacco giant a major regulatory win as the Trump administration loosens restrictions on nicotine products. ... The decision, first reported by Axios, allows 20 Zyn products to carry a modified-risk claim saying that switching from cigarettes to Zyn lowers the risk of mouth cancer, heart disease, lung cancer, stroke, emphysema and chronic bronchitis.
Zyn pouches contain nicotine but not tobacco. They are placed between a user's gum and lip and have surged in popularity among conservatives, tech workers and others who promote them as a cleaner alternative to cigarettes and chewing tobacco or a productivity aid. ... The FDA decision does not mean Zyn is safe. The agency has said there is no safe tobacco product, that youth should not use tobacco products and that adults who do not use tobacco products should not start.
Still, the order gives Philip Morris a powerful health-related claim for one of the fastest-growing products in the nicotine market, as cigarette sales continue to decline in the U.S. and major tobacco companies invest more heavily in smoke-free products. ... President Donald Trump, who backed restrictions on flavored e-cigarettes during his first term, reversed course during the 2024 campaign and promised to "save vaping." Since returning to office, his administration has taken a more industry-friendly approach, including by creating a pathway for some flavored e-cigarettes and nicotine pouches to remain on the market while they undergo FDA review. ... The shift has followed heavy lobbying from the tobacco and vaping industries, which have argued that adult smokers need more access to less harmful alternatives to cigarettes.
"President Trump consistently pledged on the campaign trail to expand access to nicotine vapes, pouches, and other products that evidence shows help adults quit smoking," White House spokesperson Kush Desai told CNBC. "The only guiding factor behind the Trump administration's decision-making is Gold Standard Science." ... Zyn has also become a cultural marker in conservative politics. Former Fox News host Tucker Carlson helped popularize the brand on the right before later souring on Zyn and launching his own nicotine pouch brand, Alp.
{snip}
FDA lets Philip Morris market Zyn nicotine pouches as less harmful than cigarettes
Published Tue, Jun 30 2026 12:52 PM EDT
Updated Tue, Jun 30 2026 4:24 PM EDT
Luke Fountain
@Luke_Fountain25
KEY POINTS
The FDA will allow 20 Philip Morris-owned Zyn nicotine pouch products to carry a modified-risk claim saying switching from cigarettes lowers the risk of several smoking-related diseases.
The decision gives Philip Morris a major marketing win for one of the fastest-growing nicotine products as cigarette sales decline in the U.S.
° Public health critics warn that flavored pouches, social media promotion and workplace use could normalize nicotine for people who were not previously smokers.

In this photo illustration, Zyn nicotine cases are seen on a table on Jan. 29, 2024, in New York City.
Michael M. Santiago | Getty Images
The Food and Drug Administration on Tuesday cleared Philip Morris-owned Zyn nicotine pouches to be marketed as less harmful than cigarettes, giving the tobacco giant a major regulatory win as the Trump administration loosens restrictions on nicotine products. ... The decision, first reported by Axios, allows 20 Zyn products to carry a modified-risk claim saying that switching from cigarettes to Zyn lowers the risk of mouth cancer, heart disease, lung cancer, stroke, emphysema and chronic bronchitis.
Zyn pouches contain nicotine but not tobacco. They are placed between a user's gum and lip and have surged in popularity among conservatives, tech workers and others who promote them as a cleaner alternative to cigarettes and chewing tobacco or a productivity aid. ... The FDA decision does not mean Zyn is safe. The agency has said there is no safe tobacco product, that youth should not use tobacco products and that adults who do not use tobacco products should not start.
Still, the order gives Philip Morris a powerful health-related claim for one of the fastest-growing products in the nicotine market, as cigarette sales continue to decline in the U.S. and major tobacco companies invest more heavily in smoke-free products. ... President Donald Trump, who backed restrictions on flavored e-cigarettes during his first term, reversed course during the 2024 campaign and promised to "save vaping." Since returning to office, his administration has taken a more industry-friendly approach, including by creating a pathway for some flavored e-cigarettes and nicotine pouches to remain on the market while they undergo FDA review. ... The shift has followed heavy lobbying from the tobacco and vaping industries, which have argued that adult smokers need more access to less harmful alternatives to cigarettes.
"President Trump consistently pledged on the campaign trail to expand access to nicotine vapes, pouches, and other products that evidence shows help adults quit smoking," White House spokesperson Kush Desai told CNBC. "The only guiding factor behind the Trump administration's decision-making is Gold Standard Science." ... Zyn has also become a cultural marker in conservative politics. Former Fox News host Tucker Carlson helped popularize the brand on the right before later souring on Zyn and launching his own nicotine pouch brand, Alp.
{snip}
4 replies
= new reply since forum marked as read
Highlight:
NoneDon't highlight anything
5 newestHighlight 5 most recent replies
FDA lets Philip Morris market Zyn nicotine pouches as less harmful than cigarettes (Original Post)
mahatmakanejeeves
Wednesday
OP
rampartd
(5,623 posts)1. has rfk declared smoking to have positive maha energy yet?
no_hypocrisy
(55,800 posts)2. That's not altogether accurate. I'd say it's equivalent, meaning
harmful in a different way. There's still the risk of oral and throat cancer, only via a different modality.
jls4561
(3,340 posts)3. How much did Phillip Morris "donate" to the ballroom?
Warpy
(114,772 posts)4. Mitigating some of the harm is not the same as ending it
but anything is better than basting your lungs with thick, black goo every half hour or so
The real need is to get off the nicotine, not trying to kid oneself into thinking it has become safe because it is not being smoked. The black goo in the lungs makes smokers sick. The nicotine is generally what kills them due to its massive effect on the cardiovascular system.
IOW, this looks like Philip Morris losing market share to vaping. and trying to convinc vapers that there is an even safer way to get thei nicotine they are dependent on.